Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Y Roth

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical Pharmacology and Therapeutics|September 10, 2010
Pharmacologic development of male hormonal contraceptive agentsM Y Roth, J K Amory
Andrology|October 11, 2015
Male hormonal contraception: looking back and moving forwardM Y Roth, S T Page, W J Bremner
International Journal of Andrology|October 26, 2010
Steady-state pharmacokinetics of oral testosterone undecanoate with concomitant inhibition of 5α-reductase by finasterideM Y Roth, R E Dudley, L Hull, et al.
The Journal of Clinical Endocrinology and Metabolism|February 4, 2011
The effect of gonadotropin withdrawal and stimulation with human chorionic gonadotropin on intratesticular androstenedione and DHEA in normal menM Y Roth, S T Page, K Lin, et al.
The Journal of Clinical Endocrinology and Metabolism|May 21, 2010
Dose-dependent increase in intratesticular testosterone by very low-dose human chorionic gonadotropin in normal men with experimental gonadotropin deficiencyM Y Roth, S T Page, K Lin, et al.
The Journal of Clinical Endocrinology and Metabolism|January 26, 2013
Androgen synthesis in the gonadotropin-suppressed human testes can be markedly suppressed by ketoconazoleM Y Roth, J J S Nya-Ngatchou, K Lin, et al.
Andrology|October 15, 2013
Characteristics associated with suppression of spermatogenesis in a male hormonal contraceptive trial using testosterone and Nestorone(®) gelsM Y Roth, N Ilani, C Wang, et al.
Andrology|April 11, 2019
Combined nestorone-testosterone gel suppresses serum gonadotropins to concentrations associated with effective hormonal contraception in menB D Anawalt, M Y Roth, J Ceponis, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Pharmacology and Therapeutics|September 10, 2010
Pharmacologic development of male hormonal contraceptive agentsM Y Roth, J K Amory
Andrology|October 11, 2015
Male hormonal contraception: looking back and moving forwardM Y Roth, S T Page, W J Bremner
International Journal of Andrology|October 26, 2010
Steady-state pharmacokinetics of oral testosterone undecanoate with concomitant inhibition of 5α-reductase by finasterideM Y Roth, R E Dudley, L Hull, et al.
The Journal of Clinical Endocrinology and Metabolism|February 4, 2011
The effect of gonadotropin withdrawal and stimulation with human chorionic gonadotropin on intratesticular androstenedione and DHEA in normal menM Y Roth, S T Page, K Lin, et al.
The Journal of Clinical Endocrinology and Metabolism|May 21, 2010
Dose-dependent increase in intratesticular testosterone by very low-dose human chorionic gonadotropin in normal men with experimental gonadotropin deficiencyM Y Roth, S T Page, K Lin, et al.
The Journal of Clinical Endocrinology and Metabolism|January 26, 2013
Androgen synthesis in the gonadotropin-suppressed human testes can be markedly suppressed by ketoconazoleM Y Roth, J J S Nya-Ngatchou, K Lin, et al.
Andrology|October 15, 2013
Characteristics associated with suppression of spermatogenesis in a male hormonal contraceptive trial using testosterone and Nestorone(®) gelsM Y Roth, N Ilani, C Wang, et al.
Andrology|April 11, 2019
Combined nestorone-testosterone gel suppresses serum gonadotropins to concentrations associated with effective hormonal contraception in menB D Anawalt, M Y Roth, J Ceponis, et al.
Pageof 1